Skip to main content
Clinical Trials/EUCTR2022-001139-98-FR
EUCTR2022-001139-98-FR
Active, not recruiting
Phase 1

Opioid-Free versus Opioid-Based Anaesthesia for secondary free-flap reconstruction surgery of the breast: A phase III multicentric randomized controlled study - OFOBA

Institut Curie0 sites158 target enrollmentApril 25, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Anaesthesia during secondary free flap reconstruction surgery of the breast.
Sponsor
Institut Curie
Enrollment
158
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 25, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Women aged 18 or older.
  • 2\.Patients with a French health insurance coverage (having a French social security number).
  • 3\.Patient eligible for secondary free flap reconstruction surgery of the breastunder general anaesthesia.
  • 4\.Patient who has given written consent to participate in accordance with the regulations.
  • 5\.Having a negative blood pregnancy test for patients of childbearing age.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 158
  • F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • 1\.Allergy or intolerance to any of the drugs (dexmedetomidine, remifentanil, lidocaine, propofol, dexamethasone, kétamine, ketoprofen, nefopam, paracetamol, morphine, ropivacaine, droperidol, ondansetron).
  • 2\.Known history of heart failure, arrhythmias and/or ischemic heart disease and/or severe renal insufficiency.
  • 3\.Pulse below 50bpm during anaesthesia consultation and/or under beta\-blocker treatment.
  • 4\.Treatment with ACEI/ARB.
  • 5\.Severe asthma.
  • 6\.Symptomatic gastric or duodenal ulcer with or without treatment.
  • 7\.Baseline systolic blood pressure \< 100 mmHg.
  • 8\.Chronic preoperative pain and/or use of WHO ladder step 2 or 3 analgesics preoperatively.
  • 9\.Patient already included in another therapeutic trial evaluating an experimental molecule.
  • 10\.Persons deprived of liberty or under guardianship.

Outcomes

Primary Outcomes

Not specified

Similar Trials